Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN).

Gabrielle JongeneelMarjolein J E GreuterFelice N van ErningMiriam KoopmanJan P MedemaRaju KandimallaAjay GoelLuis BujandaGerrit A MeijerRemond J A FijnemanMartijn G H van OijenJan IjzermansCornelis J A PuntGeraldine R VinkVeerle M H Coupé

Published in: The European journal of health economics : HEPAC : health economics in prevention and care (2020)

This model can be used to evaluate strategies for the allocation of adjuvant chemotherapy in stage II CC patients. In future studies, the model will be used to estimate population-level long-term health gain and cost-effectiveness of biomarker-based selection strategies.

Keyphrases

early stage
end stage renal disease
ejection fraction
healthcare
newly diagnosed
public health
mental health
squamous cell carcinoma
radiation therapy
sentinel lymph node
social media
patient reported
smoking cessation
health promotion